Starting Material Stabilization
TIL therapy starts from a resected tumor specimen that must be transported cold to the manufacturing site before processing. The lymphocytes held within the tissue are sensitive to the interval and conditions of transport, and their viability affects the success of the outgrowth that follows. A stabilizing protein in the transport or biopreservation medium supports cell health through shipping and hold.
Approved excipient 25% recombinant human serum albumin, supplied in bottles and closed-system friendly bags for processing, formulation, cryopreservation, and advanced biomanufacturing.
- Commonly replaces
- Serum or plasma-derived albumin in tissue transport and biopreservation media.